167 related articles for article (PubMed ID: 22299248)
1. [Atrial fibrillation. PALLAS study: when dronedarone becomes a risk].
Overbeck P
MMW Fortschr Med; 2011 Dec; 153(48):18. PubMed ID: 22299248
[No Abstract] [Full Text] [Related]
2. [Rhythm---control in atrial fibrillation].
Lewalter T
MMW Fortschr Med; 2012 Mar; 154(5):55-7. PubMed ID: 22624266
[No Abstract] [Full Text] [Related]
3. Dronedarone in atrial fibrillation: the aftermath of the PALLAS trial.
Salam AM
Expert Rev Cardiovasc Ther; 2012 Nov; 10(11):1345-9. PubMed ID: 23244355
[TBL] [Abstract][Full Text] [Related]
4. [The PALLAS study].
Disertori M; Gaita F; Blandino A; Toso E
G Ital Cardiol (Rome); 2012 May; 13(5):309-13. PubMed ID: 22539135
[No Abstract] [Full Text] [Related]
5. Dronedarone for atrial fibrillation: a new therapeutic agent.
Patel PD; Bhuriya R; Patel DD; Arora BL; Singh PP; Arora RR
Vasc Health Risk Manag; 2009; 5():635-42. PubMed ID: 19688104
[TBL] [Abstract][Full Text] [Related]
6. Dronedarone: from buzz to reality.
Le Heuzey JY
Arch Cardiovasc Dis; 2010; 103(8-9):427-9. PubMed ID: 21074120
[No Abstract] [Full Text] [Related]
7. Atrial fibrillation: Dronedarone and amiodarone-the safety versus efficacy debate.
Prystowsky EN
Nat Rev Cardiol; 2010 Jan; 7(1):5-6. PubMed ID: 20019753
[No Abstract] [Full Text] [Related]
8. Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy.
Wolbrette D; Gonzalez M; Samii S; Banchs J; Penny-Peterson E; Naccarelli G
Vasc Health Risk Manag; 2010 Aug; 6():517-23. PubMed ID: 20730068
[TBL] [Abstract][Full Text] [Related]
9. Role of dronedarone in atrial fibrillation: more questions than answers.
Hilleman DE; Mooss AN
Pharmacotherapy; 2010 Sep; 30(9):867-71. PubMed ID: 20795841
[No Abstract] [Full Text] [Related]
10. Cost-effectiveness of dronedarone in atrial fibrillation: results for Canada, Italy, Sweden, and Switzerland.
Åkerborg Ö; Nilsson J; Bascle S; Lindgren P; Reynolds M
Clin Ther; 2012 Aug; 34(8):1788-802. PubMed ID: 22770643
[TBL] [Abstract][Full Text] [Related]
11. Dronedarone (Multaq) for atrial fibrillation.
Med Lett Drugs Ther; 2009 Oct; 51(1322):78-80. PubMed ID: 19798011
[TBL] [Abstract][Full Text] [Related]
12. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
Le Heuzey JY; De Ferrari GM; Radzik D; Santini M; Zhu J; Davy JM
J Cardiovasc Electrophysiol; 2010 Jun; 21(6):597-605. PubMed ID: 20384650
[TBL] [Abstract][Full Text] [Related]
13. Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation.
Adlan AM; Lip GY
Drug Saf; 2013 Feb; 36(2):93-110. PubMed ID: 23329540
[TBL] [Abstract][Full Text] [Related]
14. Dronedarone: is it time to turn it down?
Lin L; Bai R
Expert Opin Drug Saf; 2013 Jan; 12(1):5-8. PubMed ID: 23137162
[No Abstract] [Full Text] [Related]
15. Dronedarone: where does it fit in the treatment of atrial fibrillation?
Clem JR
S D Med; 2010 Aug; 63(8):288-9. PubMed ID: 20737996
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of dronedarone: a review of randomized trials.
Christiansen CB; Torp-Pedersen C; Køber L
Expert Opin Drug Saf; 2010 Jan; 9(1):189-99. PubMed ID: 20001756
[TBL] [Abstract][Full Text] [Related]
17. Managing atrial fibrillation in the elderly: critical appraisal of dronedarone.
Trigo P; Fischer GW
Clin Interv Aging; 2012; 7():1-13. PubMed ID: 22291468
[TBL] [Abstract][Full Text] [Related]
18. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
[TBL] [Abstract][Full Text] [Related]
19. New pharmacological options for patients with atrial fibrillation: the ATHENA trial.
Hohnloser SH
Rev Esp Cardiol; 2009 May; 62(5):479-81. PubMed ID: 19406061
[No Abstract] [Full Text] [Related]
20. Second chance for dronedarone after recent setback?
Mullard A
Lancet; 2012 Feb; 379(9816):601. PubMed ID: 22355808
[No Abstract] [Full Text] [Related]
[Next] [New Search]
